Daniel Richard Zeve, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enteroendocrine Cells | 2 | 2023 | 65 | 0.850 |
Why?
|
| Stem Cells | 7 | 2022 | 3567 | 0.810 |
Why?
|
| Adipocytes | 5 | 2016 | 1184 | 0.590 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2016 | 440 | 0.470 |
Why?
|
| Cell Differentiation | 9 | 2022 | 11483 | 0.430 |
Why?
|
| Physical Conditioning, Animal | 1 | 2016 | 362 | 0.420 |
Why?
|
| Lipodystrophy | 2 | 2012 | 147 | 0.420 |
Why?
|
| Adipose Tissue | 6 | 2016 | 3279 | 0.380 |
Why?
|
| Adult Stem Cells | 1 | 2009 | 216 | 0.300 |
Why?
|
| Stem Cell Niche | 2 | 2013 | 346 | 0.300 |
Why?
|
| Muscles | 1 | 2012 | 1614 | 0.290 |
Why?
|
| Behavioral Research | 1 | 2007 | 54 | 0.290 |
Why?
|
| Peptide YY | 2 | 2023 | 130 | 0.260 |
Why?
|
| Psychology | 1 | 2007 | 356 | 0.250 |
Why?
|
| Hyperlipidemias | 1 | 2009 | 789 | 0.250 |
Why?
|
| Glypicans | 1 | 2023 | 34 | 0.240 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2023 | 340 | 0.220 |
Why?
|
| Insulin Resistance | 1 | 2016 | 3864 | 0.220 |
Why?
|
| Culture Media, Conditioned | 2 | 2016 | 537 | 0.220 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 2208 | 0.210 |
Why?
|
| Chromogranin A | 1 | 2022 | 54 | 0.210 |
Why?
|
| Anthracenes | 1 | 2022 | 84 | 0.210 |
Why?
|
| Hirschsprung Disease | 1 | 2023 | 155 | 0.210 |
Why?
|
| PPAR gamma | 4 | 2012 | 493 | 0.200 |
Why?
|
| Pseudohypoparathyroidism | 1 | 2022 | 87 | 0.200 |
Why?
|
| Chromogranins | 1 | 2022 | 160 | 0.200 |
Why?
|
| Endocannabinoids | 1 | 2022 | 116 | 0.190 |
Why?
|
| Enteric Nervous System | 1 | 2023 | 189 | 0.190 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4931 | 0.190 |
Why?
|
| Cell Lineage | 6 | 2016 | 2504 | 0.180 |
Why?
|
| Glucose | 1 | 2012 | 4397 | 0.180 |
Why?
|
| Somatostatin | 1 | 2022 | 459 | 0.180 |
Why?
|
| Wnt Proteins | 1 | 2023 | 721 | 0.170 |
Why?
|
| Quinolones | 1 | 2022 | 367 | 0.160 |
Why?
|
| Twins, Dizygotic | 1 | 2019 | 236 | 0.160 |
Why?
|
| Puberty, Precocious | 1 | 2019 | 156 | 0.150 |
Why?
|
| Osteoclasts | 2 | 2011 | 729 | 0.150 |
Why?
|
| Sexual Behavior | 1 | 2007 | 2057 | 0.150 |
Why?
|
| Bacterial Toxins | 1 | 2022 | 931 | 0.140 |
Why?
|
| beta Catenin | 2 | 2012 | 1059 | 0.140 |
Why?
|
| 3T3-L1 Cells | 1 | 2016 | 198 | 0.130 |
Why?
|
| Thrombospondins | 1 | 2016 | 197 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 3 | 2016 | 2088 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2012 | 1355 | 0.130 |
Why?
|
| GATA2 Transcription Factor | 2 | 2011 | 161 | 0.120 |
Why?
|
| Intestinal Mucosa | 2 | 2022 | 3036 | 0.120 |
Why?
|
| Physical Endurance | 1 | 2016 | 370 | 0.110 |
Why?
|
| Blood Vessels | 2 | 2009 | 1125 | 0.110 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 1150 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 11725 | 0.110 |
Why?
|
| Adipose Tissue, White | 2 | 2014 | 351 | 0.110 |
Why?
|
| Mice, Mutant Strains | 2 | 2014 | 1866 | 0.110 |
Why?
|
| Cell Proliferation | 6 | 2016 | 10481 | 0.110 |
Why?
|
| Cell Compartmentation | 1 | 2012 | 402 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 15165 | 0.090 |
Why?
|
| Mice, Transgenic | 5 | 2016 | 9734 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 687 | 0.090 |
Why?
|
| Antigens, Differentiation | 2 | 2011 | 927 | 0.090 |
Why?
|
| Mice | 13 | 2023 | 81183 | 0.090 |
Why?
|
| Ethanol | 2 | 2006 | 1342 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 1312 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2022 | 2303 | 0.080 |
Why?
|
| Tissue Transplantation | 1 | 2009 | 130 | 0.080 |
Why?
|
| Adipose Tissue, Brown | 1 | 2014 | 757 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2009 | 227 | 0.080 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 611 | 0.080 |
Why?
|
| Cerebellum | 2 | 2005 | 1488 | 0.080 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 476 | 0.080 |
Why?
|
| Animals | 17 | 2023 | 168757 | 0.080 |
Why?
|
| Adipocytes, White | 1 | 2008 | 89 | 0.080 |
Why?
|
| Behaviorism | 1 | 2007 | 3 | 0.080 |
Why?
|
| Estrogens | 1 | 2014 | 1566 | 0.070 |
Why?
|
| Biological Transport | 1 | 2012 | 2118 | 0.070 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 186 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3920 | 0.070 |
Why?
|
| Baltimore | 1 | 2007 | 231 | 0.070 |
Why?
|
| Calcium Channels, Q-Type | 1 | 2005 | 4 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 3617 | 0.070 |
Why?
|
| Calcium Channels, P-Type | 1 | 2005 | 9 | 0.070 |
Why?
|
| PC12 Cells | 1 | 2006 | 330 | 0.070 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2005 | 126 | 0.070 |
Why?
|
| Malondialdehyde | 1 | 2005 | 105 | 0.070 |
Why?
|
| Nerve Growth Factor | 1 | 2006 | 149 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2022 | 23403 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2005 | 170 | 0.060 |
Why?
|
| Homeostasis | 1 | 2016 | 3340 | 0.060 |
Why?
|
| Central Nervous System Depressants | 1 | 2005 | 167 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 2513 | 0.060 |
Why?
|
| Frizzled Receptors | 1 | 2023 | 91 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2022 | 12208 | 0.060 |
Why?
|
| Glutathione | 1 | 2005 | 589 | 0.060 |
Why?
|
| Listeriosis | 1 | 2003 | 149 | 0.050 |
Why?
|
| Adiposity | 1 | 2012 | 1807 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2023 | 220 | 0.050 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2022 | 100 | 0.050 |
Why?
|
| Cell Line | 1 | 2016 | 15997 | 0.050 |
Why?
|
| Oogenesis | 1 | 2022 | 131 | 0.050 |
Why?
|
| Caco-2 Cells | 1 | 2022 | 387 | 0.050 |
Why?
|
| Nicotine | 1 | 2006 | 681 | 0.050 |
Why?
|
| Universities | 1 | 2007 | 956 | 0.050 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2022 | 195 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2007 | 852 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2022 | 199 | 0.050 |
Why?
|
| Obesity | 2 | 2016 | 12745 | 0.040 |
Why?
|
| Insulin | 2 | 2012 | 6580 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2022 | 311 | 0.040 |
Why?
|
| Serotonin | 1 | 2023 | 1017 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2023 | 711 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2007 | 2740 | 0.040 |
Why?
|
| Growth Charts | 1 | 2019 | 61 | 0.040 |
Why?
|
| Male | 11 | 2023 | 350118 | 0.040 |
Why?
|
| Tacrolimus | 1 | 2022 | 743 | 0.040 |
Why?
|
| Collagen Type I | 2 | 2011 | 592 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2007 | 1708 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2007 | 1703 | 0.040 |
Why?
|
| Dogs | 1 | 2022 | 3912 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2022 | 1586 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 5751 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2023 | 1241 | 0.040 |
Why?
|
| Humans | 11 | 2023 | 744343 | 0.040 |
Why?
|
| Cattle | 1 | 2022 | 3922 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2016 | 25625 | 0.030 |
Why?
|
| Cell Separation | 2 | 2014 | 1751 | 0.030 |
Why?
|
| Hair | 1 | 2019 | 483 | 0.030 |
Why?
|
| Tibia | 2 | 2011 | 1077 | 0.030 |
Why?
|
| Acne Vulgaris | 1 | 2019 | 302 | 0.030 |
Why?
|
| Physical Examination | 1 | 2019 | 1237 | 0.030 |
Why?
|
| Lipids | 1 | 2023 | 3305 | 0.030 |
Why?
|
| Proteins | 1 | 2007 | 6103 | 0.030 |
Why?
|
| Osteopetrosis | 1 | 2011 | 43 | 0.030 |
Why?
|
| Cathepsin K | 1 | 2011 | 68 | 0.030 |
Why?
|
| Acid Phosphatase | 1 | 2011 | 143 | 0.030 |
Why?
|
| Drug Interactions | 2 | 2006 | 1460 | 0.020 |
Why?
|
| Mutation | 2 | 2014 | 29786 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2011 | 193 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2011 | 273 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 2011 | 321 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 4420 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2022 | 14557 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 577 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2011 | 19229 | 0.020 |
Why?
|
| Radiography | 2 | 2011 | 7023 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2005 | 2726 | 0.020 |
Why?
|
| Random Allocation | 1 | 2014 | 2429 | 0.020 |
Why?
|
| RANK Ligand | 1 | 2011 | 326 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 452 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 72290 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2022 | 3848 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 575 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2011 | 5097 | 0.020 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 502 | 0.020 |
Why?
|
| Gene Expression | 2 | 2011 | 7799 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2022 | 4286 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 1547 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 1351 | 0.020 |
Why?
|
| Doxycycline | 1 | 2008 | 326 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2005 | 6365 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 1726 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 2007 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 2252 | 0.020 |
Why?
|
| NADPH Dehydrogenase | 1 | 2005 | 45 | 0.020 |
Why?
|
| Phenothiazines | 1 | 2005 | 63 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 242 | 0.020 |
Why?
|
| Female | 6 | 2016 | 380194 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2008 | 359 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 677 | 0.020 |
Why?
|
| Chromans | 1 | 2005 | 122 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3701 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 758 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2014 | 5974 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 9438 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 3 | 2007 | 21827 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 331 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 3772 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2007 | 728 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2005 | 981 | 0.010 |
Why?
|
| Infant | 1 | 2023 | 35136 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 2003 | 250 | 0.010 |
Why?
|
| Melatonin | 1 | 2005 | 721 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2003 | 1588 | 0.010 |
Why?
|
| Rats | 2 | 2006 | 24260 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 2005 | 941 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2007 | 1373 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2007 | 1419 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2008 | 4026 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7722 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 2362 | 0.010 |
Why?
|
| Histones | 1 | 2007 | 2599 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 16365 | 0.010 |
Why?
|
| Piperazines | 1 | 2005 | 2488 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 8301 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 9648 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 77449 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2003 | 2958 | 0.010 |
Why?
|
| Neutrophils | 1 | 2003 | 3719 | 0.010 |
Why?
|
| Child | 1 | 2019 | 77709 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 9727 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 18370 | 0.010 |
Why?
|
| Cytokines | 1 | 2003 | 7322 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 13033 | 0.000 |
Why?
|
| Liver | 1 | 2003 | 7474 | 0.000 |
Why?
|
| Neurons | 1 | 2005 | 9338 | 0.000 |
Why?
|